SCHEMBL6580698

SCHEMBL6580698

CC(=O)OC(=O)c1cc(F)c(F)c(C)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 1/20 0.38
ITGA5 P08648 1/20 0.38
TSHR P16473 2/20 0.34
CES2 O00748 3/20 0.33
CES1 P23141 3/20 0.33
ALDH1A1 P00352 6/20 0.33
HTT P42858 2/20 0.32
MAPT P10636 1/20 0.31
TDP1 Q9NUW8 2/20 0.31
HSD17B10 Q99714 1/20 0.31
HSD17B1 P14061 2/20 0.31
HSD17B2 P37059 2/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31
MAOB P27338 1/20 0.30
MAPK1 P28482 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5277970 0.87 ITGB1 (0.40) ITGB1ITGA5TSHRCES2CES1
SCHEMBL6647182 0.81 MAPT (0.40) TSHRALDH1A1MAPTTDP1HSD17B10
SCHEMBL3878770 0.79 ITGB1 (0.36) ITGB1ITGA5TSHRCES2CES1
SCHEMBL2184188 0.79 TSHR (0.48) TSHRALDH1A1HTTMAPTTDP1
SCHEMBL29185124 0.77 ITGB1 (0.41) ITGB1ITGA5TSHRCES2CES1
SCHEMBL10971001 0.77 CES2 (0.40) TSHRCES2CES1ALDH1A1HSD17B1
SCHEMBL1408926 0.75 ALDH1A1 (0.43) TSHRCES2CES1ALDH1A1HSD17B1
SCHEMBL1408842 0.75 KEAP1 (0.42) CES2CES1TDP1HDAC1HDAC6
SCHEMBL31326118 0.74 CES2 (0.43) CES2CES1ALDH1A1TDP1CA1
SCHEMBL8732917 0.74 CES2 (0.43) CES2CES1ALDH1A1TDP1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0897919-B1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR SALTS THEREOF AND ANTIBACTERIAL AGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMA CO LTD (JP) 2004-06-16 EP disclosed
US-6211375-B1 IMPROVED INTESTINAL ABSORPTION WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2001-04-03 US disclosed
EP-0897919-A1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR SALTS THEREOF AND ANTIBACTERIAL AGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 1999-02-24 EP disclosed